A detailed history of New Edge Advisors, LLC transactions in Immatics N.V. stock. As of the latest transaction made, New Edge Advisors, LLC holds 104 shares of IMTX stock, worth $738. This represents 0.0% of its overall portfolio holdings.

Number of Shares
104
Previous 104 -0.0%
Holding current value
$738
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$10.23 - $12.94 $1,063 - $1,345
104 New
104 $1,000
Q4 2020

Jan 27, 2021

SELL
$9.67 - $12.05 $96,700 - $120,500
-10,000 Closed
0 $0
Q3 2020

Nov 03, 2020

BUY
$8.73 - $15.15 $87,300 - $151,500
10,000 New
10,000 $106,000

Others Institutions Holding IMTX

About Immatics N.V.


  • Ticker IMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,227,000
  • Market Cap $541M
  • Description
  • Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...
More about IMTX
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.